Clinical trials · Louisiana
Non-Muscle Invasive Bladder Neoplasms clinical trials in Louisiana
We’re tracking 3 recruiting non-muscle invasive bladder neoplasms studies with a site in Louisiana — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Louisiana
- NCT06919965RecruitingPhase 3
TAR-210 vs. standard bladder chemo for high-risk bladder cancer
This trial compares a new drug called TAR-210, given directly into the bladder, to standard chemotherapy for people with a specific type of high-risk bladder cancer that has not invaded muscle. It tests if TAR-210 can be more effective with fewer side effects.
Lafayette, LouisianaAges 18 years+ - NCT06319820RecruitingPhase 3
TAR-210 vs standard bladder chemo for FGFR-mutated bladder cancer
This trial compares a new drug, TAR-210, which is placed directly into the bladder, against standard chemotherapy given through a catheter. It is for people with a specific type of bladder cancer that has a change in the FGFR gene.
New Orleans, LouisianaAges 18 years+ - NCT06833073RecruitingPhase 2
Study of an mRNA vaccine and BCG for bladder cancer
This trial tests an experimental mRNA vaccine (V940) combined with BCG therapy for people with high-risk non-muscle invasive bladder cancer that hasn't spread. It aims to see if the vaccine can help the immune system better fight the cancer.
Lafayette, LouisianaAges 18 years+
Where these studies are running in Louisiana
Institutions with a site for the recruiting non-muscle invasive bladder neoplasms studies listed above.
- Southern Urology · 2 studies
- Ochsner Health System
What taking part in a non-muscle invasive bladder neoplasms study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Non-Muscle Invasive Bladder Neoplasms trials in other states
Common questions
- Are there non-muscle invasive bladder neoplasms clinical trials in Louisiana?
- Yes. We're currently tracking 3 recruiting non-muscle invasive bladder neoplasms studies with a site in Louisiana, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a non-muscle invasive bladder neoplasms study in Louisiana?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Louisiana to take part?
- Not necessarily. These studies have a site in Louisiana, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a non-muscle invasive bladder neoplasms trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New non-muscle invasive bladder neoplasms studies open in Louisiana regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.